Glory Health Industry Limited (HKG:2329)
Hong Kong · Delayed Price · Currency is HKD 0.1090
+0.0130 (13.54%)
Sep 10, 2026, 3:17 PM HKT
Glory Health Industry Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 850.98 | 1,036 | 2,705 | 2,506 | 3,905 | 9,898 | |
Revenue Growth | -58.33% | -61.72% | 7.94% | -35.81% | -60.55% | 71.58% |
Cost of Revenue | 1,056 | 1,344 | 2,150 | 2,557 | 3,791 | 8,651 |
Gross Profit | -204.84 | -308.09 | 555.56 | -50.28 | 113.52 | 1,247 |
Selling, General & Admin | 254.49 | 243.61 | 277.35 | 406.71 | 460.57 | 667.52 |
Operating Expenses | 290.26 | 279.38 | 308.87 | 411.13 | 528.65 | 751.22 |
Operating Income | -495.11 | -587.47 | 246.7 | -461.41 | -415.14 | 496.02 |
Interest Expense | -925.42 | -847.34 | -1,004 | -502.67 | -451.59 | -744.91 |
Interest & Investment Income | 0.24 | 0.24 | 65.58 | 73.56 | 74.26 | 83.94 |
Earnings From Equity Investments | - | - | -69.93 | -72.56 | 42.03 | 166.39 |
Currency Exchange Gain (Loss) | 61.88 | 61.88 | -13.72 | -18.76 | -350.02 | 444.53 |
Other Non Operating Income (Expenses) | -191.68 | -284.76 | -86.58 | -24.29 | -0.66 | 24.86 |
EBT Excluding Unusual Items | -1,550 | -1,657 | -861.63 | -1,006 | -1,101 | 470.82 |
Gain (Loss) on Sale of Assets | -791.34 | -799.71 | -17.72 | 146.12 | 2.45 | 332.01 |
Asset Writedown | 47.88 | 47.88 | -498.94 | 263.5 | 20.06 | 115.7 |
Other Unusual Items | 507.64 | 507.64 | -58.03 | -58.95 | -11.75 | -41.66 |
Pretax Income | -1,786 | -1,902 | -1,436 | -655.46 | -1,090 | 876.87 |
Income Tax Expense | 85.55 | -132.24 | -20.81 | -61.96 | -95.05 | 532.35 |
Earnings From Continuing Operations | -1,871 | -1,769 | -1,416 | -593.5 | -995.29 | 344.52 |
Minority Interest in Earnings | -50.95 | -53.09 | 175.07 | 29.53 | 82.51 | -116.18 |
Net Income | -1,922 | -1,822 | -1,240 | -563.97 | -912.78 | 228.33 |
Net Income to Common | -1,922 | -1,822 | -1,240 | -563.97 | -912.78 | 228.33 |
Net Income Growth | - | - | - | - | - | 131.25% |
Shares Outstanding (Basic) | 4,447 | 4,444 | 4,444 | 4,444 | 4,444 | 4,444 |
Shares Outstanding (Diluted) | 4,447 | 4,444 | 4,444 | 4,444 | 4,444 | 4,444 |
Shares Change | 0.07% | - | - | - | - | - |
EPS (Basic) | -0.43 | -0.41 | -0.28 | -0.13 | -0.21 | 0.05 |
EPS (Diluted) | -0.43 | -0.41 | -0.28 | -0.13 | -0.21 | 0.05 |
EPS Growth | - | - | - | - | - | 131.42% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 53.44 | 678.26 | 452.11 | 413.47 | 4,066 |
Free Cash Flow Per Share | - | 0.01 | 0.15 | 0.10 | 0.09 | 0.92 |
Gross Margin | -24.07% | -29.75% | 20.54% | -2.01% | 2.91% | 12.60% |
Operating Margin | -58.18% | -56.73% | 9.12% | -18.41% | -10.63% | 5.01% |
Profit Margin | -225.91% | -175.98% | -45.85% | -22.50% | -23.38% | 2.31% |
Free Cash Flow Margin | - | 5.16% | 25.07% | 18.04% | 10.59% | 41.08% |
EBITDA | -448.82 | -542.9 | 320.62 | -384.83 | -325.93 | 581.55 |
EBITDA Margin | -52.74% | -52.42% | 11.85% | -15.35% | -8.35% | 5.88% |
D&A For EBITDA | 46.29 | 44.57 | 73.93 | 76.58 | 89.2 | 85.53 |
EBIT | -495.11 | -587.47 | 246.7 | -461.41 | -415.14 | 496.02 |
EBIT Margin | -58.18% | -56.73% | 9.12% | -18.41% | -10.63% | 5.01% |
Effective Tax Rate | - | - | - | - | - | 60.71% |
Revenue as Reported | 850.98 | 1,036 | 2,705 | 2,506 | 3,905 | 9,898 |